Increased leukocyte Rho-associated coiled-coil containing protein kinase activity predicts the presence and severity of coronary vasospastic angina.
暂无分享,去创建一个
J. Liao | Chao-Hung Wang | N. Yang | W. Cherng | Ming-Yow Hung | M. Hung | Chi-Wen Cheng | L. Kuo
[1] William Grossman,et al. Grossman & Baim's Cardiac Catheterization, Angiography, and Intervention , 2013 .
[2] Yoshihiro Fukumoto,et al. Rho-kinase: important new therapeutic target in cardiovascular diseases. , 2011, American journal of physiology. Heart and circulatory physiology.
[3] T. Glück. Long-Term Prognosis of , 2011 .
[4] K. Chayama,et al. Calcium channel blocker and Rho-associated kinase activity in patients with hypertension , 2011, Journal of hypertension.
[5] K. Hsu,et al. Interactions among gender, age, hypertension and C‐reactive protein in coronary vasospasm , 2010, European journal of clinical investigation.
[6] M. Hung. Current advances in the understanding of coronary vasospasm. , 2010, World journal of cardiology.
[7] P. Ganz,et al. Statins inhibit Rho kinase activity in patients with atherosclerosis. , 2009, Atherosclerosis.
[8] J. Liao,et al. Evidence for Statin Pleiotropy in Humans: Differential Effects of Statins and Ezetimibe on Rho-Associated Coiled-Coil Containing Protein Kinase Activity, Endothelial Function, and Inflammation , 2009, Circulation.
[9] F. Luscinskas,et al. ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury. , 2008, The Journal of clinical investigation.
[10] H. Yasue,et al. Coronary artery spasm--clinical features, diagnosis, pathogenesis, and treatment. , 2008, Journal of cardiology.
[11] J. Liao,et al. Rho Kinase (ROCK) Inhibitors , 2007, Journal of cardiovascular pharmacology.
[12] P. Ganz,et al. Rho Kinase Inhibition Improves Endothelial Function in Human Subjects With Coronary Artery Disease , 2006, Circulation research.
[13] K. Nakao,et al. A −786T>C polymorphism in the endothelial nitric oxide synthase gene reduces serum nitrite/nitrate levels from the heart due to an intracoronary injection of acetylcholine , 2006, Pharmacogenetics and genomics.
[14] Takahiro Shimizu,et al. Calcium Channel Blockades Exhibit Anti-Inflammatory and Antioxidative Effects by Augmentation of Endothelial Nitric Oxide Synthase and the Inhibition of Angiotensin Converting Enzyme in the NG-Nitro-L-Arginine Methyl Ester-Induced Hypertensive Rat Aorta: Vasoprotective Effects beyond the Blood Press , 2005, Hypertension Research.
[15] A. Takeshita,et al. Remnant Lipoproteins from Patients with Sudden Cardiac Death Enhance Coronary Vasospastic Activity Through Upregulation of Rho-Kinase , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[16] Céline Marionneau,et al. RhoA Expression Is Controlled by Nitric Oxide through cGMP-dependent Protein Kinase Activation* , 2003, The Journal of Biological Chemistry.
[17] A. Takeshita,et al. Evidence for Protein Kinase C-Mediated Activation of Rho- Kinase in a Porcine Model of Coronary Artery Spasm , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[18] H. Shimokawa,et al. Rho-Kinase Mediates Hypoxia-Induced Downregulation of Endothelial Nitric Oxide Synthase , 2002, Circulation.
[19] A. Takeshita,et al. Suppression of Coronary Artery Spasm by the Rho-Kinase Inhibitor Fasudil in Patients With Vasospastic Angina , 2002, Circulation.
[20] R. Webb,et al. Nitric Oxide Induces Dilation of Rat Aorta via Inhibition of Rho-Kinase Signaling , 2002, Hypertension.
[21] J. Keaney. Grossman's cardiac catheterization, angiography, and intervention, 6th ed , 2001 .
[22] A. Ridley,et al. Monocyte Adhesion and Spreading on Human Endothelial Cells Is Dependent on Rho-regulated Receptor Clustering , 1999, The Journal of cell biology.
[23] J. Brown,et al. Rho and Rho kinase mediate thrombin-stimulated vascular smooth muscle cell DNA synthesis and migration. , 1999, Circulation research.
[24] K. Nakao,et al. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. , 1996, Circulation.
[25] Hirofumiyasue,et al. Nitric Oxide Activity Is Deficient in Spasm Arteries of Patients With Coronary Spastic Angina , 1996 .
[26] M. Horie,et al. Long-term prognosis for patients with variant angina and influential factors. , 1988, Circulation.
[27] A. Maseri,et al. Long-term prognosis of "variant" angina with medical treatment. , 1980, The American journal of cardiology.
[28] M. Cheitlin. Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis , 2009 .
[29] T. Aizawa,et al. Histological evaluation of coronary plaque in patients with variant angina: relationship between vasospasm and neointimal hyperplasia in primary coronary lesions. , 1999, Journal of the American College of Cardiology.